New Achievement
-
- 脂質ナノ粒子
Apr 17, 2025Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery -
- Expression Vector
Apr 07, 2025The host-vector system developed jointly with Fuso Pharmaceutical Industries, Ltd. has been commercialized by the company. -
- COVID-19
Apr 01, 2025Collaboration with Shionogi for drug discovery –Shionogi & Co., Ltd. has submitted a rolling submission to the U.S. Food and Drug Administration (FDA) for Xocova as a prevention measure against COVID-19.